View Author

Noordzij, M.A.

( M.A. Noordzij)


tumor cancer prostate prostate cancer expression prostatic patient study androgen prognostic tissue model prognostic value marker growth differentiation score receptor neuroendocrine value analysis antibody specimen number androgen withdrawal progression level stage prostatectomy grade gleason carcinoma protein -67 figure castration result chapter factor staining antigen prognosis bcl -2 slide neuroendocrine differentiation biopsy prostatic carcinoma androgen receptor volume van der kwast pathol adenocarcinoma treatment immunohistochemical system prostatectomy specimens cd 44s ki -67 table pattern section correlation survival bcl -2 expression -295 xenograft metastatic -310 relationship group method cd 44v cd 44 prostate cancer patients prognostic markers withdrawal lymph proliferation presence tumor volume




4 Most Recent Publications

Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation (Article)
Jongsma, J. Oomen, M.H. Noordzij, M.A. Weerden, W.M. van Martens, G.J. Kwast, Th.H. van der Schröder, F.H. Steenbrugge, G.J. van
2000-01-01
Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma (Article)
Ghanem, M.A. Kwast, Th.H. van der Hollander, J.C. den Sudaryo, M.K. Oomen, M.H. Noordzij, M.A. Heuvel, M.M. van den Nassef, S.M. Nijman, J.M. Steenbrugge, G.J. van
2000-01-01
Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model (Article)
Jongsma, J. Oomen, M.H. Noordzij, M.A. Weerden, W.M. van Martens, G.J. Kwast, Th.H. van der Schröder, F.H. Steenbrugge, G.J. van
1999-01-01
The application of prognostic tissue markers to prostate cancer : clinical and experimental studies (Doctoral Thesis)
Noordzij, M.A.
1997-03-19